Margie Suggs, MD
Radiation Oncology · Jackson, MSNPI 1225325699
Payments from drug & device makers
What this record shows
Siemens Medical Solutions USA, Inc. accounts for 70.1% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $675 and has fallen 89.3% since, to $72 in 2025.
Across 17 payments — averaging $63.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Siemens Medical Solutions USA, Inc.$757
- Novocure Inc.$166
- Teleflex LLC$42
- Blue Earth Diagnostics$41
- Viewray Technologies Inc$28
- Novartis$16
- plus $30 from 2 others
What the payments were for
- Travel & lodging$62758%
- Food & beverage$45242%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Siemens Medical Solutions USA, Inc. | 7 | $757 |
| Novocure Inc. | 2 | $166 |
| Teleflex LLC | 2 | $42 |
| Blue Earth Diagnostics | 2 | $41 |
| Viewray Technologies Inc | 1 | $28 |
| Novartis | 1 | $16 |
| Puma Biotechnology, Inc. | 1 | $16 |
| Tactile Systems Technology Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,079 in reported general payments places this provider in the 60th percentile of 36 radiation oncology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 149 | $1,508 |
| SsdSilver Sulfadiazine | 14 | $267 |
| Silver Sulfadiazine | 18 | $191 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Jackson
- Jimmy CaudellJackson$17K
- Srinivasan VijayakumarJackson$5K
- Teessa Perekattu KuruvillaJackson$3K
- Sidney JohnsonJackson$1K
- Eric BalfourJackson$947
- Satyaseelan PackianathanJackson$747
- Eswara MundraJackson$417
- Steven ZachowJackson$183
- Richard FriedmanJackson$120
- Toms Vengaloor ThomasJackson$109
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.